Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
Want to cut your energy bills? Here’s how five experts are doing it 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes 
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
DUBLIN, Ireland, May 26, 2017 -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate at the following conferences in June:
Jefferies 2017 Global Healthcare Conference
- Date: June 6, 2017
- Presentation Time: 11:30 a.m. ET
- Location: New York, NY
The JMP Securities Life Science Conference
- Presentation Date: June 21, 2017
- Presentation Time: 1:30 p.m. ET
- Location: New York, NY
The conferences presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts:
| Investors: | U.S. Media: |
| Tina Ventura | Geoff Curtis |
| Senior Vice President, | Senior Vice President, |
| Investor Relations | Corporate Affairs & Chief Communications Officer |
| [email protected] | [email protected] |
| Ruth Venning | Ireland Media: |
| Executive Director, | Ray Gordon |
| Investor Relations | Gordon MRM |
| [email protected] | [email protected] |
